divendres, 17 de febrer del 2017

Fresenius Kabi launches Dilaudid injection in Simplist prefilled syringes

Fresenius Kabi launches Dilaudid injection in Simplist prefilled syringes

Fresenius (NYSE:FMS) business group Fresenius Kabi said today that its Dilaudid hydromorphone HCl injection is available in 4 different presentations of the Simplest prefilled syringes.

The Lake Zurich-Ill. company’s Simplist syringes have a 2-year shelf life and do not require any assembly or point-of care preparation.

Get the full story at our sister site, Drug Delivery Business News.

The post Fresenius Kabi launches Dilaudid injection in Simplist prefilled syringes appeared first on MassDevice.



from MassDevice http://ift.tt/2ls3pKS

Cap comentari:

Publica un comentari a l'entrada